A designed ankyrin-repeat protein that targets Parkinson's disease-associated LRRK2.
Dederer V, Sanz Murillo M, Karasmanis EP, Hatch KS, Chatterjee D, Preuss F, Abdul Azeez KR, Vu Nguyen L, Galicia C, Dreier B, Plückthun A, Versees W, Mathea S, Leschziner AE, Reck-Peterson SL, Knapp S.
Dederer V, et al. Among authors: chatterjee d.
J Biol Chem. 2024 Jun 12:107469. doi: 10.1016/j.jbc.2024.107469. Online ahead of print.
J Biol Chem. 2024.
PMID: 38876305
Free article.